Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
FDA Accepts BLA for Imsidolimab as Generalized Pustular Psoriasis Treatment

FDA Accepts BLA for Imsidolimab as Generalized Pustular Psoriasis Treatment

Indeterminate Consultant Live
Owner: Mike Hennessy Jr.
Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Accelerates As 70+ Pharma Companies Rigorously Develop Drugs For Market Entry  Delveinsight

Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Accelerates As 70+ Pharma Companies Rigorously Develop Drugs For Market Entry Delveinsight

Esophageal Cancer Clinical Trial Pipeline Accelerates As 80+ Pharma Companies Rigorously Develop Drugs For Market Entry  Delveinsight

Esophageal Cancer Clinical Trial Pipeline Accelerates As 80+ Pharma Companies Rigorously Develop Drugs For Market Entry Delveinsight

Conservative opposition to Trump drug pricing plan partly bankrolled by pharmaceutical industry

Conservative opposition to Trump drug pricing plan partly bankrolled by pharmaceutical industry

Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors

<![CDATA[Competitive Simulation – Defining Strategy Through Lived Experiences]]>

<![CDATA[Competitive Simulation – Defining Strategy Through Lived Experiences]]>

Asahi Kasei Pharma strengthens preclinical pipeline

Asahi Kasei Pharma strengthens preclinical pipeline

INTERPHEX WEEK TOKYO to expand its 2026 showcase

INTERPHEX WEEK TOKYO to expand its 2026 showcase

New Evidence on Meal Timing and Crohn’s Disease Outcomes, With Andres Hurtado-Lorenzo, PhD

New Evidence on Meal Timing and Crohn’s Disease Outcomes, With Andres Hurtado-Lorenzo, PhD

Indeterminate Consultant Live
Owner: Mike Hennessy Jr.
<![CDATA[How Does FDA's Decision Represent a Broader Regulatory Recalibration?]]>

<![CDATA[How Does FDA's Decision Represent a Broader Regulatory Recalibration?]]>

Indeterminate Pharmaceutical Executive
Owner: Mike Hennessy Jr.
Resolving 'Toxic' Healthcare Leadership with SCAN Health Plan CEO Sachin Jain

Resolving 'Toxic' Healthcare Leadership with SCAN Health Plan CEO Sachin Jain

Indeterminate HealthLeaders - Tennessee
Owner: Leeds Equity Partners
Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Accelerates As 70+ Pharma Companies Rigorously Develop Drugs For Market Entry  Delveinsight

Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Accelerates As 70+ Pharma Companies Rigorously Develop Drugs For Market Entry Delveinsight

Esophageal Cancer Clinical Trial Pipeline Accelerates As 80+ Pharma Companies Rigorously Develop Drugs For Market Entry  Delveinsight

Esophageal Cancer Clinical Trial Pipeline Accelerates As 80+ Pharma Companies Rigorously Develop Drugs For Market Entry Delveinsight

Conservative opposition to Trump drug pricing plan partly bankrolled by pharmaceutical industry

Conservative opposition to Trump drug pricing plan partly bankrolled by pharmaceutical industry

Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors

<![CDATA[Competitive Simulation – Defining Strategy Through Lived Experiences]]>

<![CDATA[Competitive Simulation – Defining Strategy Through Lived Experiences]]>

Asahi Kasei Pharma strengthens preclinical pipeline

Asahi Kasei Pharma strengthens preclinical pipeline

INTERPHEX WEEK TOKYO to expand its 2026 showcase

INTERPHEX WEEK TOKYO to expand its 2026 showcase

New Evidence on Meal Timing and Crohn’s Disease Outcomes, With Andres Hurtado-Lorenzo, PhD

New Evidence on Meal Timing and Crohn’s Disease Outcomes, With Andres Hurtado-Lorenzo, PhD

<![CDATA[How Does FDA's Decision Represent a Broader Regulatory Recalibration?]]>

<![CDATA[How Does FDA's Decision Represent a Broader Regulatory Recalibration?]]>

Resolving 'Toxic' Healthcare Leadership with SCAN Health Plan CEO Sachin Jain

Resolving 'Toxic' Healthcare Leadership with SCAN Health Plan CEO Sachin Jain

FDA Accepts BLA for Imsidolimab as Generalized Pustular Psoriasis Treatment

FDA Accepts BLA for Imsidolimab as Generalized Pustular Psoriasis Treatment

Show More

Video Stories

YouTube video thumbnail: How Social Media are Shaping Kids' Mental Health
Play
How Social Media are Shaping Kids' Mental Health
YouTube video thumbnail: Teen who Lost leg to Cancer Scores Long-Awaited Basket
Play
Teen who Lost leg to Cancer Scores Long-Awaited Basket
YouTube video thumbnail: Novo Nordisk to Halve US List Price of Wegovy in 2027
Play
Novo Nordisk to Halve US List Price of Wegovy in 2027
YouTube video thumbnail: If Food is Medicine, how About a Prescription for Blueberries?
Play
If Food is Medicine, how About a Prescription for Blueberries?

Video Title

Press Releases

Scientists sharpen genetic maps to help pinpoint DNA changes that influence human health traits and disease risk

Scientists sharpen genetic maps to help pinpoint DNA changes that influence human health traits and disease risk

Free genetic testing program aims to improve medical care across Alabama

Free genetic testing program aims to improve medical care across Alabama

Our open letter in response to stigmatising and inaccurate Telegraph article

Our open letter in response to stigmatising and inaccurate Telegraph article

Health officials alert public of potential measles exposures at Denver International Airport, Littleton church

Health officials alert public of potential measles exposures at Denver International Airport, Littleton church

RCP responds to the government’s announcement widening access to obesity treatments, calling for a long-term treatment strategy and clarity on funding

RCP responds to the government’s announcement widening access to obesity treatments, calling for a long-term treatment strategy and clarity on funding

RCP responds to the government’s announcement widening access to obesity treatments, calling for a long-term treatment strategy and clarity on funding

RCP responds to the government’s announcement widening access to obesity treatments, calling for a long-term treatment strategy and clarity on funding

Dynamic Stem Cell Therapy - 712579 - 02/11/2026

Dynamic Stem Cell Therapy - 712579 - 02/11/2026

Scientists sharpen genetic maps to help pinpoint DNA changes that influence human health traits and disease risk

Scientists sharpen genetic maps to help pinpoint DNA changes that influence human health traits and disease risk

Free genetic testing program aims to improve medical care across Alabama

Free genetic testing program aims to improve medical care across Alabama

Our open letter in response to stigmatising and inaccurate Telegraph article

Our open letter in response to stigmatising and inaccurate Telegraph article

Health officials alert public of potential measles exposures at Denver International Airport, Littleton church

Health officials alert public of potential measles exposures at Denver International Airport, Littleton church

RCP responds to the government’s announcement widening access to obesity treatments, calling for a long-term treatment strategy and clarity on funding

RCP responds to the government’s announcement widening access to obesity treatments, calling for a long-term treatment strategy and clarity on funding

RCP responds to the government’s announcement widening access to obesity treatments, calling for a long-term treatment strategy and clarity on funding

RCP responds to the government’s announcement widening access to obesity treatments, calling for a long-term treatment strategy and clarity on funding

Dynamic Stem Cell Therapy - 712579 - 02/11/2026

Dynamic Stem Cell Therapy - 712579 - 02/11/2026

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions